Go Pro
→ Iran War WARNING: Something Just Changed (From Banyan Hill Publishing) (Ad)tc pixel Free RSSS Stock Alerts

Research Solutions (RSSS) Financials

Research Solutions logo
$2.07 -0.02 (-0.96%)
Closing price 09/18/2026 04:00 PM Eastern
Extended Trading
$2.08 +0.02 (+0.72%)
As of 09/18/2026 07:30 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for Research Solutions

Annual Income Statements for Research Solutions

This table shows Research Solutions' income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025 6/30/2026
Net Income / (Loss) Attributable to Common Shareholders		 -0.50 -2.29 -1.68 -0.96 -19 -0.29 -1.63 0.57 -3.79 1.27 2.82
Consolidated Net Income / (Loss)		 -0.50 -2.29 -1.68 -0.96 -0.66 -0.29 -1.63 0.57 -3.79 1.27 2.82
Net Income / (Loss) Continuing Operations		 -1.36 -3.11 -1.94 -1.17 -0.78 -0.29 -1.63 0.57 -3.79 1.27 2.82
Total Pre-Tax Income 		-1.34 -3.07 -1.90 -1.15 -0.77 -0.28 -1.62 0.58 -3.67 1.35 2.96
Total Operating Income		 -1.29 -3.08 -1.95 -1.25 -0.85 -0.28 -1.63 0.24 -0.77 2.50 3.59
Total Gross Profit		 5.63 6.10 7.35 8.34 9.64 10 12 15 20 24 25
Total Revenue		 24 26 28 29 27 32 33 38 45 49 48
Operating Revenue		 24 26 28 29 27 32 33 38 45 49 48
Total Cost of Revenue		 18 20 21 20 43 21 21 23 25 25 23
Operating Cost of Revenue		 18 20 21 20 43 21 21 23 25 25 23
Total Operating Expenses		 6.92 9.19 9.30 9.60 10 11 14 14 20 22 21
Selling, General & Admin Expense		 6.83 9.06 9.15 9.56 10 11 14 14 20 20 20
Depreciation Expense		 0.09 0.13 0.15 0.04 0.02 0.01 0.02 0.05 0.84 1.25 1.25
Total Other Income / (Expense), net		 -0.05 0.01 0.05 0.11 0.08 0.00 0.01 0.34 -2.90 -1.15 -0.63
Interest Expense		 0.02 0.01 0.00 - - - - - - 0.00 1.04
Other Income / (Expense), net		 -0.03 0.02 0.06 0.11 0.08 0.00 0.01 0.34 -2.90 -1.15 0.41
Income Tax Expense		 0.03 0.04 0.04 0.03 0.01 0.00 0.01 0.01 0.11 0.08 0.13
Basic Earnings per Share		 ($0.03) ($0.10) ($0.07) ($0.04) ($0.03) - ($0.06) $0.02 ($0.13) $0.04 $0.09
Weighted Average Basic Shares Outstanding		 17.77M 23.24M 23.47M 23.82M 24.76M 26.01M 26.42M 26.86M 28.86M 30.68M 31.79M
Diluted Earnings per Share		 ($0.03) ($0.10) ($0.07) ($0.04) ($0.03) - ($0.06) $0.02 ($0.13) $0.04 $0.09
Weighted Average Diluted Shares Outstanding		 17.77M 23.24M 23.47M 23.82M 24.76M 26.01M 26.42M 29.14M 28.86M 31.50M 32.27M
Weighted Average Basic & Diluted Shares Outstanding		 17.77M 23.24M 23.47M 23.82M 24.76M 26.01M 27.33M 29.60M 32.55M 32.83M 33.76M

Quarterly Income Statements for Research Solutions

This table shows Research Solutions' income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Income / (Loss) Attributable to Common Shareholders		 -0.05 0.08 -2.82 0.67 -1.98 0.22 2.36 0.75 0.55 0.86 0.67
Consolidated Net Income / (Loss)		 -0.05 0.08 -2.82 0.67 -1.98 0.22 2.36 0.75 0.55 0.86 0.67
Net Income / (Loss) Continuing Operations		 -0.05 0.08 -2.82 0.67 -1.98 0.22 2.36 0.75 0.55 0.86 0.67
Total Pre-Tax Income 		-0.04 0.12 -2.79 0.72 -1.97 0.23 2.37 0.77 0.56 0.88 0.75
Total Operating Income		 -0.42 0.09 0.66 0.65 0.09 0.56 1.20 0.96 0.74 1.04 0.84
Total Gross Profit		 4.48 5.48 5.64 5.77 5.82 6.27 6.34 6.23 6.18 6.27 6.40
Total Revenue		 10 12 12 12 12 13 12 12 12 12 12
Operating Revenue		 10 12 12 12 12 13 12 12 12 12 12
Total Cost of Revenue		 5.83 6.63 6.49 6.28 6.09 6.39 6.10 6.09 5.62 5.86 5.68
Operating Cost of Revenue		 5.83 6.63 6.49 6.28 6.09 6.39 6.10 6.09 5.62 5.86 5.68
Total Operating Expenses		 4.90 5.39 4.98 5.12 5.73 5.71 5.14 5.26 5.44 5.22 5.56
Selling, General & Admin Expense		 4.75 5.08 4.67 4.81 5.42 5.40 4.82 4.95 5.12 4.91 5.25
Depreciation Expense		 0.16 0.31 0.31 0.31 0.31 0.31 0.32 0.32 0.32 0.31 0.31
Total Other Income / (Expense), net		 0.38 0.03 -3.45 0.07 -2.06 -0.33 1.16 -0.19 -0.18 -0.16 -0.10
Other Income / (Expense), net		 0.38 0.03 -3.45 0.07 -2.06 -0.33 1.16 -0.19 -0.18 0.08 0.70
Income Tax Expense		 0.01 0.04 0.03 0.05 0.02 0.01 0.01 0.02 0.01 0.02 0.08
Basic Earnings per Share		 $0.00 $0.00 ($0.09) $0.02 ($0.07) $0.01 $0.08 $0.02 $0.02 $0.03 $0.02
Weighted Average Basic Shares Outstanding		 28.09M 30.02M 28.86M 30.35M 30.42M 31.03M 30.68M 31.23M 31.63M 32.00M 31.79M
Diluted Earnings per Share		 $0.00 $0.00 ($0.09) $0.02 ($0.07) $0.01 $0.08 $0.02 $0.02 $0.03 $0.02
Weighted Average Diluted Shares Outstanding		 28.09M 33.51M 28.86M 31.20M 30.42M 32.14M 31.50M 32.07M 32.33M 32.44M 32.27M
Weighted Average Basic & Diluted Shares Outstanding		 32.62M 32.28M 32.55M 32.51M 32.65M 32.46M 32.83M 32.87M 32.91M 33.45M 33.76M

Annual Cash Flow Statements for Research Solutions

This table details how cash moves in and out of Research Solutions' business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025 6/30/2026
Net Change in Cash & Equivalents		 4.72 -0.30 -0.87 0.66 3.96 1.69 -0.40 2.94 -7.45 6.13 0.40
Net Cash From Operating Activities		 0.19 -0.44 -0.61 0.58 2.42 1.87 -0.42 3.38 3.55 7.02 5.27
Net Cash From Continuing Operating Activities		 0.19 -0.44 -0.61 0.79 2.42 1.87 -0.42 3.38 3.55 7.02 5.27
Net Income / (Loss) Continuing Operations		 -0.50 -2.29 -1.68 -1.17 -0.66 -0.29 -1.63 0.57 -3.79 1.27 2.82
Consolidated Net Income / (Loss)		 -0.50 -2.29 -1.68 -0.96 -0.66 -0.29 -1.63 0.57 -3.79 1.27 2.82
Depreciation Expense		 0.09 0.13 0.15 0.04 0.02 0.01 0.02 0.05 0.84 1.25 1.25
Non-Cash Adjustments To Reconcile Net Income		 0.71 0.39 1.01 0.83 0.83 1.01 1.03 1.92 2.16 1.72 1.97
Changes in Operating Assets and Liabilities, net		 -0.12 1.29 -0.20 0.77 2.10 1.06 0.17 0.84 4.35 2.79 -0.77
Net Cash From Investing Activities		 -0.20 0.36 -0.09 -0.02 0.00 -0.02 -0.04 -0.34 -10 -0.02 -0.04
Net Cash From Continuing Investing Activities		 -0.20 0.36 -0.09 -0.02 0.00 -0.02 -0.04 -0.34 -10 -0.02 -0.04
Purchase of Property, Plant & Equipment		 -0.06 -0.06 -0.03 -0.02 0.00 -0.02 -0.04 -0.34 -0.07 -0.02 -0.04
Net Cash From Financing Activities		 4.75 -0.20 -0.15 -0.10 1.55 -0.16 0.06 -0.10 -0.91 -0.88 -4.85
Net Cash From Continuing Financing Activities		 4.75 -0.20 -0.15 -0.10 1.55 -0.16 0.06 -0.10 -0.91 -0.88 -4.85
Repurchase of Common Equity		 -0.04 -0.20 -0.15 -0.20 -0.32 -0.18 -0.09 -0.10 -0.55 -0.93 -0.05
Other Financing Activities, net		 - - - 0.10 1.88 0.33 0.16 0.01 -0.35 0.06 -4.79
Effect of Exchange Rate Changes		 -0.01 -0.03 -0.02 -0.02 -0.01 - -0.00 - - - 0.01
Cash Income Taxes Paid		 0.03 0.04 0.04 0.03 0.01 0.00 0.01 0.01 0.11 0.08 0.07

Quarterly Cash Flow Statements for Research Solutions

This table details how cash moves in and out of Research Solutions' business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
Net Change in Cash & Equivalents		 -7.18 1.52 1.88 0.82 0.78 2.15 2.38 -0.27 0.31 -0.21 0.58
Net Cash From Operating Activities		 0.33 2.02 1.96 0.84 1.03 2.89 2.26 1.11 1.38 1.01 1.78
Net Cash From Continuing Operating Activities		 0.33 2.02 1.96 0.84 1.03 2.89 2.26 1.11 1.38 1.01 1.78
Net Income / (Loss) Continuing Operations		 -0.05 0.08 -2.82 0.67 -1.98 0.22 2.36 0.75 0.55 0.86 0.67
Consolidated Net Income / (Loss)		 -0.05 0.08 -2.82 0.67 -1.98 0.22 2.36 0.75 0.55 0.86 0.67
Depreciation Expense		 0.16 0.31 0.31 0.31 0.31 0.31 0.32 0.32 0.32 0.31 0.31
Non-Cash Adjustments To Reconcile Net Income		 0.60 0.54 0.43 0.42 0.53 0.59 0.18 0.21 0.21 1.09 0.45
Changes in Operating Assets and Liabilities, net		 -0.37 1.09 4.05 -0.56 2.17 1.77 -0.59 -0.17 0.31 -1.26 0.35
Net Cash From Investing Activities		 -7.33 -0.00 -0.01 0.00 -0.01 -0.01 -0.01 -0.02 -0.01 -0.00 -0.01
Net Cash From Continuing Investing Activities		 -7.33 -0.00 -0.01 0.00 -0.01 -0.01 -0.01 -0.02 -0.01 -0.00 -0.01
Purchase of Property, Plant & Equipment		 -0.02 -0.00 -0.01 0.00 -0.01 -0.01 -0.01 -0.02 -0.01 -0.00 -0.01
Net Cash From Financing Activities		 -0.19 -0.49 -0.07 -0.02 -0.25 -0.73 0.12 -1.36 -1.08 -1.22 -1.19
Net Cash From Continuing Financing Activities		 -0.19 -0.49 -0.07 -0.02 -0.25 -0.73 0.12 -1.36 -1.08 -1.22 -1.19
Repurchase of Common Equity		 -0.02 -0.45 -0.03 -0.02 -0.19 -0.70 -0.03 -0.02 -0.02 -0.01 -0.01
Other Financing Activities, net		 -0.17 -0.04 -0.04 0.00 -0.06 -0.03 0.15 -1.34 -1.06 -1.21 -1.18
Effect of Exchange Rate Changes		 - - - - - -0.00 - 0.00 - - 0.01
Cash Income Taxes Paid		 0.01 0.04 0.03 0.05 0.02 0.01 0.01 0.02 0.01 0.02 0.02

Annual Balance Sheets for Research Solutions

This table presents Research Solutions' assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025 6/30/2026
Total Assets		 12 13 9.96 10 15 17 17 22 42 46 46
Total Current Assets		 12 12 9.58 10 15 17 17 21 15 20 21
Cash & Equivalents		 6.08 5.77 4.91 5.35 9.31 11 11 14 6.10 12 13
Accounts Receivable		 5.76 5.47 4.25 4.49 4.45 4.72 5.25 6.15 6.88 7.19 6.96
Prepaid Expenses		 0.34 0.76 0.42 0.32 0.96 1.18 1.12 1.60 1.71 0.58 1.10
Plant, Property, & Equipment, net		 0.08 0.09 0.06 0.04 0.01 0.02 0.05 0.07 0.09 0.06 0.06
Total Noncurrent Assets		 0.11 0.47 0.32 0.21 0.08 0.00 0.00 0.46 27 26 25
Goodwill		 - - - - - - - 0.00 16 16 16
Intangible Assets		 0.10 0.04 - - - - 0.00 0.46 11 9.69 8.54
Other Noncurrent Operating Assets		 0.01 0.43 0.32 0.21 0.08 0.00 0.00 0.00 0.00 0.00 0.00
Total Liabilities & Shareholders' Equity		 12 13 9.96 10 15 17 17 22 42 46 46
Total Liabilities		 6.33 8.22 6.68 7.38 9.95 11 12 15 30 32 25
Total Current Liabilities		 6.33 7.89 6.47 7.30 9.95 11 12 15 18 26 25
Short-Term Debt		 - - - - - - - - 0.00 7.36 7.32
Accounts Payable		 5.69 6.44 4.69 4.86 6.35 6.69 6.60 8.08 8.84 7.44 6.15
Current Deferred Revenue		 0.64 1.34 1.67 2.31 3.52 4.80 5.54 6.42 9.02 11 11
Total Noncurrent Liabilities		 0.00 0.33 0.21 0.08 0.00 0.00 0.00 0.00 12 6.68 0.02
Noncurrent Deferred Revenue		 - - - - - - - - - 0.00 0.02
Other Noncurrent Operating Liabilities		 0.00 0.33 0.21 0.08 - - - 0.00 12 6.68 0.00
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 6.04 4.34 3.28 3.03 4.86 5.43 4.88 7.33 12 14 21
Total Preferred & Common Equity		 6.04 4.34 3.28 3.03 4.86 5.43 4.88 7.33 12 14 21
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 6.04 4.34 3.28 3.03 4.86 5.43 4.88 7.33 12 14 21
Common Stock		 22 22 23 24 26 27 28 30 38 39 43
Retained Earnings		 -16 -18 -20 -21 -21 -21 -23 -23 -26 -25 -22
Accumulated Other Comprehensive Income / (Loss)		 -0.04 -0.07 -0.09 -0.11 -0.13 -0.12 -0.12 -0.12 -0.12 -0.12 -0.10

Quarterly Balance Sheets for Research Solutions

This table presents Research Solutions' assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q1 2025 Q2 2025 Q3 2025 Q1 2026 Q2 2026 Q3 2026
Period end date 9/30/2023 12/31/2023 3/31/2024 9/30/2024 12/31/2024 3/31/2025 9/30/2025 12/31/2025 3/31/2026
Total Assets		 24 39 41 41 43 45 46 44 46
Total Current Assets		 18 12 13 14 16 19 20 19 21
Cash & Equivalents		 9.88 2.70 4.22 6.92 7.70 9.85 12 12 12
Accounts Receivable		 6.46 7.29 7.32 6.30 7.12 7.60 6.90 5.66 7.60
Prepaid Expenses		 1.48 1.63 1.64 1.22 1.33 1.38 0.80 0.75 1.03
Plant, Property, & Equipment, net		 0.09 0.10 0.09 0.07 0.06 0.06 0.07 0.07 0.06
Total Noncurrent Assets		 5.77 28 28 27 27 26 26 26 25
Goodwill		 3.24 16 16 16 16 16 16 16 16
Intangible Assets		 2.53 11 11 10 10 9.96 9.41 9.13 8.84
Other Noncurrent Operating Assets		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Liabilities & Shareholders' Equity		 24 39 41 41 43 45 46 44 46
Total Liabilities		 17 25 27 29 32 34 30 27 27
Total Current Liabilities		 15 17 18 16 21 25 25 24 25
Short-Term Debt		 - - - - 3.96 6.02 7.30 7.30 7.31
Accounts Payable		 8.54 8.86 9.01 8.26 8.10 8.53 7.60 6.40 6.69
Current Deferred Revenue		 6.39 7.84 8.87 8.05 8.85 10 9.98 9.92 11
Total Noncurrent Liabilities		 1.87 8.79 8.79 12 11 9.09 5.04 3.41 1.78
Noncurrent Deferred Revenue		 - - - - - - - - 0.06
Other Noncurrent Operating Liabilities		 1.87 8.79 8.79 12 11 9.09 5.04 3.41 1.73
Commitments & Contingencies		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 6.89 14 14 13 11 11 16 17 19
Total Preferred & Common Equity		 6.89 14 14 13 11 11 16 17 19
Preferred Stock		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Total Common Equity		 6.89 14 14 13 11 11 16 17 19
Common Stock		 31 38 38 39 39 39 40 41 42
Retained Earnings		 -24 -24 -23 -26 -28 -27 -24 -24 -23
Accumulated Other Comprehensive Income / (Loss)		 -0.12 -0.11 -0.11 -0.12 -0.12 -0.13 -0.12 -0.11 -0.11

Annual Metrics And Ratios for Research Solutions

This table displays calculated financial ratios and metrics derived from Research Solutions' official financial filings.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026
Period end date 6/30/2016 6/30/2017 6/30/2018 6/30/2019 6/30/2020 6/30/2021 6/30/2022 6/30/2023 6/30/2024 6/30/2025 6/30/2026
DEI Shares Outstanding		 18,582,860.00 23,925,910.00 23,980,383.00 24,334,102.00 26,034,572.00 26,352,008.00 27,064,215.00 29,500,764.00 32,282,039.00 32,458,727.00 33,447,532.00
DEI Adjusted Shares Outstanding		 18,582,860.00 23,925,910.00 23,980,383.00 24,334,102.00 26,034,572.00 26,352,008.00 27,064,215.00 29,500,764.00 32,282,039.00 32,458,727.00 33,447,532.00
DEI Earnings Per Adjusted Shares Outstanding		 -0.03 -0.10 -0.07 -0.04 -0.73 -0.01 -0.06 0.02 -0.12 0.04 0.08
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 -24.48% 6.87% 8.82% 2.77% -5.65% 16.89% 3.71% 14.48% 18.35% 9.94% -1.53%
EBITDA Growth		 -285.50% -134.78% 43.48% 38.99% 36.78% 68.48% -711.54% 139.19% -550.45% 191.42% 102.43%
EBIT Growth		 -167.28% -132.16% 38.19% 39.34% 32.75% 63.48% -476.39% 135.53% -736.41% 136.70% 196.31%
NOPAT Growth		 -160.23% -139.72% 36.78% 35.65% 32.12% 66.78% -476.58% 120.68% -327.97% 535.81% 45.97%
Net Income Growth		 -164.30% -360.69% 26.81% 42.82% 31.01% 56.95% -472.59% 135.02% -762.43% 133.42% 122.99%
EPS Growth		 -175.00% -233.33% 30.00% 42.86% 25.00% 0.00% 0.00% 133.33% -750.00% 130.77% 125.00%
Operating Cash Flow Growth		 155.79% -335.91% -38.57% 195.23% 319.55% -22.74% -122.33% 911.09% 4.94% 97.78% -24.90%
Free Cash Flow Firm Growth		 -9.35% 32.01% -52.23% 84.05% 925.73% -39.63% -207.94% 173.16% -1,787.58% 90.91% -159.22%
Invested Capital Growth		 86.29% -3,890.53% -13.95% -42.52% -91.81% -25.26% -2.55% -8.66% 190.01% 62.03% 69.90%
Revenue Q/Q Growth		 -28.40% 52.05% 1.18% 1.08% -11.35% 15.34% 1.06% 3.85% 5.12% 0.62% -0.73%
EBITDA Q/Q Growth		 -62.20% 6.42% 27.41% -4.82% 18.99% -152.71% -27.40% 415.21% -7,208.42% 200.97% -13.70%
EBIT Q/Q Growth		 -57.91% 5.07% 24.63% -2.00% 16.33% -45.51% -27.31% 344.78% -623.82% 135.39% -17.17%
NOPAT Q/Q Growth		 -57.51% 4.53% 23.57% -2.82% 17.33% -42.29% -27.76% 173.34% 34.56% 71.26% -12.10%
Net Income Q/Q Growth		 30.92% -17.98% 15.89% 1.37% 9.72% -44.88% -27.23% 335.83% -542.21% 132.32% -37.52%
EPS Q/Q Growth		 40.00% -11.11% 22.22% -33.33% 0.00% 0.00% 0.00% 300.00% -333.33% 130.77% -40.00%
Operating Cash Flow Q/Q Growth		 -69.33% 65.67% -21.93% -18.22% 85.26% -43.97% 44.69% 82.14% 14.50% 4.43% -8.40%
Free Cash Flow Firm Q/Q Growth		 -249.48% 72.48% -117.50% -553.25% 306.41% -62.18% 33.38% 1,742.30% 25.03% -128.93% 3.76%
Invested Capital Q/Q Growth		 95.26% -504.76% -9.57% 2.54% -27.91% 8.12% -4.70% -8.27% -43.53% 22.51% 7.54%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 23.39% 23.71% 26.23% 28.98% 35.48% 32.39% 36.50% 38.99% 44.01% 49.32% 51.90%
EBITDA Margin		 -5.10% -11.19% -5.81% -3.45% -2.31% -0.62% -4.88% 1.67% -6.36% 5.29% 10.87%
Operating Margin		 -5.34% -11.98% -6.96% -4.36% -3.14% -0.89% -4.96% 0.63% -1.72% 5.10% 7.43%
EBIT Margin		 -5.47% -11.89% -6.75% -3.99% -2.84% -0.89% -4.93% 1.53% -8.23% 2.75% 8.27%
Profit (Net Income) Margin		 -2.07% -8.91% -5.99% -3.33% -2.44% -0.90% -4.96% 1.52% -8.49% 2.58% 5.84%
Tax Burden Percent		 37.27% 74.64% 88.54% 83.65% 85.80% 101.14% 100.47% 99.03% 103.08% 93.86% 95.50%
Interest Burden Percent		 101.32% 100.39% 100.21% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 73.96%
Effective Tax Rate		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.97% 0.00% 6.14% 4.50%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 32.03% 28.02%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 51.77% 39.91%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -22.15% -11.72%
Return on Equity (ROE)		 -13.96% -44.17% -44.04% -30.42% -16.79% -5.54% -31.66% 9.36% -39.81% 9.88% 16.30%
Cash Return on Invested Capital (CROIC)		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% -220.72% -15.31% -23.78%
Operating Return on Assets (OROA)		 -13.57% -24.55% -16.80% -11.27% -6.12% -1.78% -9.57% 2.97% -11.53% 3.07% 8.71%
Return on Assets (ROA)		 -5.13% -18.40% -14.91% -9.42% -5.25% -1.80% -9.62% 2.94% -11.89% 2.88% 6.15%
Return on Common Equity (ROCE)		 -13.96% -44.17% -44.04% -30.42% -16.79% -5.54% -31.66% 9.36% -39.81% 9.88% 16.30%
Return on Equity Simple (ROE_SIMPLE)		 -8.24% -52.79% -51.19% -31.66% -13.63% -5.25% -33.43% 7.80% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -0.90 -2.16 -1.37 -0.88 -0.60 -0.20 -1.14 0.24 -0.54 2.35 3.43
NOPAT Margin		 -3.74% -8.39% -4.87% -3.05% -2.20% -0.62% -3.47% 0.63% -1.21% 4.79% 7.09%
Net Nonoperating Expense Percent (NNEP)		 10.84% -2.27% -5.87% -1.59% -0.90% -0.86% -4.54% 2.78% -33.07% -19.74% -11.89%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - - -4.61% 11.03% 12.23%
Cost of Revenue to Revenue		 76.61% 76.29% 73.77% 71.02% 157.69% 67.61% 63.50% 61.01% 55.99% 50.68% 48.10%
SG&A Expenses to Revenue		 28.35% 35.17% 32.65% 33.20% 38.52% 33.25% 41.40% 38.22% 43.86% 41.68% 41.87%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 28.73% 35.69% 33.19% 33.33% 38.61% 33.28% 41.45% 38.36% 45.74% 44.22% 44.47%
Earnings before Interest and Taxes (EBIT)		 -1.32 -3.06 -1.89 -1.15 -0.77 -0.28 -1.62 0.58 -3.67 1.35 4.00
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -1.23 -2.88 -1.63 -0.99 -0.63 -0.20 -1.61 0.63 -2.84 2.59 5.25
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 3.69 6.61 9.51 22.31 12.70 13.89 9.86 8.21 7.04 6.69 3.75
Price to Tangible Book Value (P/TBV)		 3.76 6.67 9.51 22.31 12.70 13.89 9.86 8.76 0.00 0.00 0.00
Price to Revenue (P/Rev)		 0.93 1.12 1.11 2.35 2.27 2.37 1.46 1.60 1.84 1.90 1.61
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 105.28 0.00 73.61 27.50
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.95% 0.00% 1.36% 3.64%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 13.62 9.74 4.69
Enterprise Value to Revenue (EV/Rev)		 0.67 0.89 0.94 2.16 1.93 2.03 1.14 1.24 1.71 1.80 1.50
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 74.04 0.00 34.04 13.77
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 80.79 0.00 65.48 18.09
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 197.37 0.00 37.61 21.10
Enterprise Value to Operating Cash Flow (EV/OCF)		 87.61 0.00 0.00 108.07 21.66 34.45 0.00 13.78 21.46 12.57 13.71
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 34.13 69.46 0.00 63.74 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.53 0.35
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 -1.04 -1.14 -1.40 -1.63 -1.86 -1.98 -2.10 -1.98 -1.03 -0.43 -0.29
Leverage Ratio		 2.72 2.40 2.95 3.23 3.20 3.08 3.29 3.18 3.35 3.43 2.65
Compound Leverage Factor		 2.76 2.41 2.96 3.23 3.20 3.08 3.29 3.18 3.35 3.43 1.96
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 34.58% 26.13%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 34.58% 26.13%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 65.42% 73.87%
Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 2.84 1.39
Net Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -1.88 -1.01
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 3.14 2.14
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -2.07 -1.55
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 2.51 1.74 2.61 5.47 3.77 4.36 2.44 3.23 1.44 1.99 2.42
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 1.92 1.52 1.48 1.39 1.48 1.47 1.40 1.47 0.82 0.78 0.83
Quick Ratio		 1.87 1.42 1.42 1.35 1.38 1.37 1.31 1.36 0.73 0.76 0.79
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -1.13 -0.77 -1.17 -0.19 1.53 0.93 -1.00 0.73 -12 -1.12 -2.91
Operating Cash Flow to CapEx		 317.20% -733.02% -2,067.05% 3,641.94% 0.00% 9,410.73% -942.02% 981.80% 4,965.67% 36,463.14% 13,261.97%
Free Cash Flow to Firm to Interest Expense		 -64.79 -63.81 -291.41 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -2.80
Operating Cash Flow to Interest Expense		 10.65 -36.40 -151.33 0.00 0.00 0.00 0.00 0.00 0.00 0.00 5.07
Operating Cash Flow Less CapEx to Interest Expense		 7.29 -41.37 -158.65 0.00 0.00 0.00 0.00 0.00 0.00 0.00 5.03
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 2.48 2.07 2.49 2.83 2.15 2.00 1.94 1.94 1.40 1.12 1.05
Accounts Receivable Turnover		 4.41 4.59 5.77 6.59 6.08 6.93 6.61 6.61 6.85 6.97 6.83
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 291.24 306.62 387.05 600.68 1,129.55 1,982.85 958.22 638.08 564.13 659.47 808.89
Accounts Payable Turnover		 3.27 3.24 3.71 4.28 7.64 3.29 3.15 3.13 2.95 3.05 3.42
Days Sales Outstanding (DSO)		 82.75 79.58 63.29 55.42 60.07 52.68 55.24 55.20 53.30 52.35 53.47
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 111.75 112.73 98.27 85.22 47.76 110.82 115.98 116.50 123.62 119.56 106.76
Cash Conversion Cycle (CCC)		 -29.00 -33.15 -34.98 -29.80 12.31 -58.14 -60.74 -61.29 -70.32 -67.21 -53.29
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 -0.04 -1.43 -1.63 -2.32 -4.45 -5.58 -5.72 -6.21 5.59 9.06 15
Invested Capital Turnover		 -162.15 -35.15 -18.32 -14.58 -8.02 -6.33 -5.83 -6.32 -143.79 6.69 3.95
Increase / (Decrease) in Invested Capital		 0.23 -1.39 -0.20 -0.69 -2.13 -1.12 -0.14 -0.50 12 3.47 6.34
Enterprise Value (EV)		 16 23 26 62 52 64 38 47 76 88 72
Market Capitalization		 22 29 31 68 62 75 48 60 82 93 78
Book Value per Share		 $0.33 $0.18 $0.14 $0.12 $0.19 $0.21 $0.18 $0.25 $0.36 $0.43 $0.62
Tangible Book Value per Share		 $0.32 $0.18 $0.14 $0.12 $0.19 $0.21 $0.18 $0.23 ($0.48) ($0.37) ($0.13)
Total Capital		 6.04 4.34 3.28 3.03 4.86 5.43 4.88 7.33 12 21 28
Total Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 7.36 7.32
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 -6.08 -5.77 -4.91 -5.35 -9.31 -11 -11 -14 -6.10 -4.86 -5.31
Capital Expenditures (CapEx)		 0.06 0.06 0.03 0.02 0.00 0.02 0.04 0.34 0.07 0.02 0.04
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -0.23 -1.66 -1.80 -2.49 -4.54 -5.60 -5.77 -6.75 -9.28 -10 -9.55
Debt-free Net Working Capital (DFNWC)		 5.85 4.11 3.11 2.87 4.77 5.41 4.83 6.80 -3.18 1.85 3.08
Net Working Capital (NWC)		 5.85 4.11 3.11 2.87 4.77 5.41 4.83 6.80 -3.18 -5.51 -4.25
Net Nonoperating Expense (NNE)		 -0.40 0.13 0.31 0.08 0.07 0.09 0.49 -0.34 3.25 1.08 0.60
Net Nonoperating Obligations (NNO)		 -6.08 -5.77 -4.91 -5.35 -9.31 -11 -11 -14 -6.10 -4.86 -5.31
Total Depreciation and Amortization (D&A)		 0.09 0.18 0.26 0.15 0.14 0.08 0.02 0.05 0.84 1.25 1.25
Debt-free, Cash-free Net Working Capital to Revenue		 -0.96% -6.45% -6.43% -8.63% -16.72% -17.63% -17.51% -17.90% -20.79% -21.15% -19.78%
Debt-free Net Working Capital to Revenue		 24.27% 15.97% 11.09% 9.96% 17.55% 17.02% 14.68% 18.03% -7.12% 3.78% 6.37%
Net Working Capital to Revenue		 24.27% 15.97% 11.09% 9.96% 17.55% 17.02% 14.68% 18.03% -7.12% -11.23% -8.79%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 ($0.03) ($0.10) ($0.07) ($0.04) ($0.03) ($0.01) $0.00 $0.02 ($0.13) $0.04 $0.09
Adjusted Weighted Average Basic Shares Outstanding		 17.77M 24.17M 24.19M 24.47M 26.21M 26.62M 27.33M 26.86M 28.86M 30.68M 31.79M
Adjusted Diluted Earnings per Share		 ($0.03) ($0.10) ($0.07) ($0.04) ($0.03) ($0.01) $0.00 $0.02 ($0.13) $0.04 $0.09
Adjusted Weighted Average Diluted Shares Outstanding		 17.77M 24.17M 24.19M 24.47M 26.21M 26.62M 27.33M 29.14M 28.86M 31.50M 32.27M
Adjusted Basic & Diluted Earnings per Share		 ($0.03) ($0.10) ($0.07) ($0.04) ($0.03) ($0.01) $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 23.91M 23.24M 23.47M 23.82M 24.76M 26.01M 27.33M 29.60M 32.55M 32.83M 33.76M
Normalized Net Operating Profit after Tax (NOPAT)		 -0.90 -2.16 -1.37 -0.88 -0.60 -0.20 -1.14 0.24 -0.54 2.35 3.43
Normalized NOPAT Margin		 -3.74% -8.39% -4.87% -3.05% -2.20% -0.62% -3.47% 0.63% -1.21% 4.79% 7.09%
Pre Tax Income Margin		 -5.54% -11.93% -6.77% -3.99% -2.84% -0.89% -4.93% 1.53% -8.23% 2.75% 6.12%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 -75.84 -255.06 -472.99 0.00 0.00 0.00 0.00 0.00 0.00 0.00 3.84
NOPAT to Interest Expense		 -51.82 -179.93 -341.27 0.00 0.00 0.00 0.00 0.00 0.00 0.00 3.29
EBIT Less CapEx to Interest Expense		 -79.20 -260.03 -480.31 0.00 0.00 0.00 0.00 0.00 0.00 0.00 3.80
NOPAT Less CapEx to Interest Expense		 -55.18 -184.90 -348.59 0.00 0.00 0.00 0.00 0.00 0.00 0.00 3.26
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 -7.58% -8.69% -9.10% -20.84% -48.56% -62.44% -5.75% 18.24% -14.64% 73.85% 1.88%

Quarterly Metrics And Ratios for Research Solutions

This table displays calculated financial ratios and metrics derived from Research Solutions' official financial filings.

Metric Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026 Q2 2026 Q3 2026 Q4 2026
Period end date 12/31/2023 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026 6/30/2026
DEI Shares Outstanding		 29,624,085.00 32,620,507.00 32,282,039.00 32,554,568.00 32,513,172.00 32,646,827.00 32,458,727.00 32,828,173.00 - 32,905,476.00 33,447,532.00
DEI Adjusted Shares Outstanding		 29,624,085.00 32,620,507.00 32,282,039.00 32,554,568.00 32,513,172.00 32,646,827.00 32,458,727.00 32,828,173.00 - 32,905,476.00 33,447,532.00
DEI Earnings Per Adjusted Shares Outstanding		 0.00 0.00 -0.09 0.02 -0.06 0.01 0.07 0.02 - 0.03 0.02
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 18.32% 17.15% 21.83% 19.71% 15.52% 4.50% 2.51% 2.22% -1.02% -4.26% -2.87%
EBITDA Growth		 145.16% 67.63% -722.96% 214.27% -1,578.73% 26.38% 208.23% 5.78% 152.58% 165.98% -31.05%
EBIT Growth		 82.90% -49.93% -842.46% 174.61% -4,409.97% 93.35% 184.88% 7.75% 128.28% 391.08% -34.97%
NOPAT Growth		 -27.49% -57.63% 81.48% 178.63% 122.11% 832.17% 159.20% 54.60% 1,019.45% 94.25% -37.44%
Net Income Growth		 79.01% -67.78% -850.83% 167.71% -3,592.54% 183.71% 183.66% 12.02% 127.62% 297.38% -71.80%
EPS Growth		 100.00% -100.00% -1,000.00% 150.00% 0.00% 0.00% 188.89% 0.00% 128.57% 200.00% -75.00%
Operating Cash Flow Growth		 -64.07% 137.60% 29.75% 211.59% 212.88% 43.44% 15.18% 31.31% 34.59% -65.16% -21.41%
Free Cash Flow Firm Growth		 -7,342.87% -3,898.62% -1,611.50% -189.24% 122.95% 119.45% 80.00% 49.35% -205.15% -294.64% -146.11%
Invested Capital Growth		 300.64% 272.58% 190.01% 294.80% -34.41% -25.32% 62.03% 87.43% 65.94% 93.55% 69.90%
Revenue Q/Q Growth		 2.51% 17.47% 0.15% -0.73% -1.08% 6.27% -1.76% -1.01% -4.22% 2.79% -0.34%
EBITDA Q/Q Growth		 112.48% 282.24% -678.19% 141.44% -261.47% 132.67% 395.18% -59.50% -19.74% 65.25% 28.37%
EBIT Q/Q Growth		 95.45% 372.87% -2,446.86% 125.63% -374.75% 111.70% 930.24% -67.46% -27.88% 103.12% 36.43%
NOPAT Q/Q Growth		 61.78% 119.14% 723.36% 30.59% -89.26% 706.91% 128.95% -22.11% -22.20% 40.02% -26.26%
Net Income Q/Q Growth		 94.57% 242.28% -3,797.50% 123.71% -396.00% 110.93% 990.36% -68.25% -27.02% 57.28% -22.63%
EPS Q/Q Growth		 100.00% 0.00% 0.00% 122.22% -450.00% 114.29% 700.00% -75.00% 0.00% 50.00% -33.33%
Operating Cash Flow Q/Q Growth		 143.50% 513.56% -2.75% -57.01% 21.97% 181.29% -21.91% -50.99% 25.01% -27.17% 76.12%
Free Cash Flow Firm Q/Q Growth		 -504.02% 9.22% 27.23% 27.51% 147.93% -23.06% -174.82% -83.57% 0.50% -42.42% 5.39%
Invested Capital Q/Q Growth		 476.16% -12.06% -43.53% 4.29% 26.66% 0.13% 22.51% 20.64% 12.13% 16.79% 7.54%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 43.47% 45.25% 46.51% 47.87% 48.86% 49.50% 50.99% 50.56% 52.38% 51.69% 53.00%
EBITDA Margin		 1.09% 3.54% -20.43% 8.53% -13.92% 4.28% 21.57% 8.83% 7.40% 11.89% 15.32%
Operating Margin		 -4.07% 0.72% 5.45% 5.37% 0.78% 4.40% 9.69% 7.81% 6.27% 8.62% 6.97%
EBIT Margin		 -0.42% 0.98% -23.00% 5.94% -16.49% 1.82% 19.04% 6.26% 4.71% 9.31% 12.75%
Profit (Net Income) Margin		 -0.52% 0.63% -23.25% 5.55% -16.62% 1.71% 18.98% 6.09% 4.64% 7.10% 5.51%
Tax Burden Percent		 123.08% 64.18% 101.11% 93.54% 100.77% 94.17% 99.66% 97.24% 98.41% 97.49% 89.18%
Interest Burden Percent		 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 100.00% 78.16% 48.46%
Effective Tax Rate		 0.00% 35.82% 0.00% 6.46% 0.00% 5.83% 0.34% 2.76% 1.59% 2.51% 10.82%
Return on Invested Capital (ROIC)		 -41.04% 9.46% 0.00% 164.89% 2.82% 23.34% 64.62% 44.68% 30.90% 37.66% 24.56%
ROIC Less NNEP Spread (ROIC-NNEP)		 -44.48% 9.22% 0.00% 164.12% 66.39% 30.99% 43.46% 47.89% 35.05% 41.36% 26.24%
Return on Net Nonoperating Assets (RNNOA)		 31.66% -7.35% 0.00% -140.40% -17.03% -9.84% -18.60% -19.57% -10.76% -11.70% -7.71%
Return on Equity (ROE)		 -9.37% 2.12% -39.81% 24.48% -14.21% 13.50% 46.02% 25.12% 20.14% 25.96% 16.85%
Cash Return on Invested Capital (CROIC)		 -156.86% -166.25% -220.72% -139.62% 52.73% 44.83% -15.31% -28.63% -14.81% -27.84% -23.78%
Operating Return on Assets (OROA)		 -0.61% 1.36% -32.22% 8.51% -19.33% 2.06% 21.23% 7.11% 5.33% 9.94% 13.42%
Return on Assets (ROA)		 -0.75% 0.87% -32.58% 7.96% -19.48% 1.94% 21.16% 6.91% 5.24% 7.58% 5.80%
Return on Common Equity (ROCE)		 -9.37% 2.12% -39.81% 24.48% -14.21% 13.50% 46.02% 25.12% 20.14% 25.96% 16.85%
Return on Equity Simple (ROE_SIMPLE)		 -3.07% -4.17% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 -0.29 0.06 0.46 0.60 0.06 0.52 1.20 0.94 0.73 1.02 0.75
NOPAT Margin		 -2.85% 0.46% 3.82% 5.02% 0.55% 4.14% 9.65% 7.60% 6.17% 8.40% 6.22%
Net Nonoperating Expense Percent (NNEP)		 3.44% 0.25% -33.44% 0.76% -63.57% -7.65% 21.15% -3.21% -4.15% -3.70% -1.68%
Return On Investment Capital (ROIC_SIMPLE)		 -2.11% 0.40% 3.96% 4.74% 0.43% 3.04% 5.64% 4.09% 2.97% 3.86% 2.68%
Cost of Revenue to Revenue		 56.53% 54.75% 53.49% 52.13% 51.14% 50.50% 49.01% 49.44% 47.62% 48.31% 47.00%
SG&A Expenses to Revenue		 46.04% 41.97% 38.49% 39.91% 45.51% 42.63% 38.77% 40.18% 43.43% 40.49% 43.46%
R&D to Revenue		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Operating Expenses to Revenue		 47.55% 44.52% 41.05% 42.50% 48.08% 45.10% 41.30% 42.75% 46.11% 43.07% 46.03%
Earnings before Interest and Taxes (EBIT)		 -0.04 0.12 -2.79 0.72 -1.97 0.23 2.37 0.77 0.56 1.13 1.54
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 0.11 0.43 -2.48 1.03 -1.66 0.54 2.68 1.09 0.87 1.44 1.85
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 5.52 7.30 7.04 6.97 12.13 7.56 6.69 7.85 5.61 3.90 3.75
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Price to Revenue (P/Rev)		 1.89 2.43 1.84 1.91 2.80 1.74 1.90 2.48 1.96 1.53 1.61
Price to Earnings (P/E)		 0.00 0.00 0.00 0.00 0.00 0.00 73.61 90.98 24.95 16.46 27.50
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 1.36% 1.10% 4.01% 6.07% 3.64%
Enterprise Value to Invested Capital (EV/IC)		 6.60 9.98 13.62 14.05 17.75 10.95 9.74 10.77 7.48 4.86 4.69
Enterprise Value to Revenue (EV/Rev)		 1.83 2.33 1.71 1.76 2.72 1.66 1.80 2.39 1.86 1.43 1.50
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 2,476.81 0.00 0.00 0.00 0.00 34.04 44.40 17.68 11.45 13.77
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 0.00 0.00 0.00 65.48 83.91 23.36 14.43 18.09
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 119.94 125.87 59.13 37.61 43.62 26.82 17.86 21.10
Enterprise Value to Operating Cash Flow (EV/OCF)		 38.44 31.88 21.46 15.91 22.43 12.05 12.57 16.16 11.99 12.09 13.71
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 26.67 20.89 0.00 0.00 0.00 0.00 0.00
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 0.00 0.36 0.54 0.53 0.47 0.42 0.38 0.35
Long-Term Debt to Equity		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Financial Leverage		 -0.71 -0.80 -1.03 -0.86 -0.26 -0.32 -0.43 -0.41 -0.31 -0.28 -0.29
Leverage Ratio		 2.89 2.99 3.35 3.31 3.28 3.39 3.43 3.06 3.07 3.01 2.65
Compound Leverage Factor		 2.89 2.99 3.35 3.31 3.28 3.39 3.43 3.06 3.07 2.35 1.28
Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 26.27% 34.89% 34.58% 31.87% 29.75% 27.72% 26.13%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 26.27% 34.89% 34.58% 31.87% 29.75% 27.72% 26.13%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Common Equity to Total Capital		 100.00% 100.00% 100.00% 100.00% 73.73% 65.11% 65.42% 68.13% 70.25% 72.28% 73.87%
Debt to EBITDA		 0.00 0.00 0.00 0.00 -1.48 -2.34 2.84 2.75 1.41 1.20 1.39
Net Debt to EBITDA		 0.00 0.00 0.00 0.00 1.39 1.49 -1.88 -1.76 -0.96 -0.78 -1.01
Long-Term Debt to EBITDA		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Debt to NOPAT		 0.00 0.00 0.00 0.00 3.80 4.39 3.14 2.70 2.13 1.88 2.14
Net Debt to NOPAT		 0.00 0.00 0.00 0.00 -3.59 -2.80 -2.07 -1.73 -1.45 -1.22 -1.55
Long-Term Debt to NOPAT		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Altman Z-Score		 1.85 2.42 1.51 2.13 2.49 1.58 2.07 2.71 2.41 1.99 2.24
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 0.70 0.74 0.82 0.89 0.77 0.76 0.78 0.79 0.79 0.82 0.83
Quick Ratio		 0.60 0.65 0.73 0.81 0.71 0.70 0.76 0.76 0.76 0.78 0.79
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 -17 -16 -11 -8.22 3.94 3.03 -2.27 -4.17 -4.14 -5.90 -5.58
Operating Cash Flow to CapEx		 1,498.24% 100,934.88% 14,264.04% 0.00% 19,029.87% 46,907.05% 29,374.71% 6,312.33% 19,710.30% 24,900.52% 15,904.60%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -23.94 0.00
Operating Cash Flow to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 4.09 0.00
Operating Cash Flow Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 4.07 0.00
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 1.43 1.38 1.40 1.43 1.17 1.13 1.12 1.14 1.13 1.07 1.05
Accounts Receivable Turnover		 6.49 6.01 6.85 7.31 6.69 6.53 6.97 7.47 7.70 6.40 6.83
Inventory Turnover		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Fixed Asset Turnover		 513.73 574.26 564.13 571.92 578.90 632.63 659.47 702.88 765.28 825.45 808.89
Accounts Payable Turnover		 3.34 2.94 2.95 3.00 3.01 2.88 3.05 3.11 3.34 3.11 3.42
Days Sales Outstanding (DSO)		 56.23 60.71 53.30 49.96 54.53 55.88 52.35 48.83 47.39 57.02 53.47
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Days Payable Outstanding (DPO)		 109.23 124.29 123.62 121.50 121.45 126.75 119.56 117.31 109.39 117.40 106.76
Cash Conversion Cycle (CCC)		 -53.00 -63.59 -70.32 -71.54 -66.91 -70.87 -67.21 -68.48 -62.00 -60.38 -53.29
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 11 9.91 5.59 5.83 7.39 7.40 9.06 11 12 14 15
Invested Capital Turnover		 14.40 20.38 -143.79 32.83 5.17 5.63 6.69 5.88 5.01 4.48 3.95
Increase / (Decrease) in Invested Capital		 17 16 12 8.83 -3.88 -2.51 3.47 5.10 4.87 6.92 6.34
Enterprise Value (EV)		 74 99 76 82 131 81 88 118 92 70 72
Market Capitalization		 77 103 82 89 135 85 93 122 97 74 78
Book Value per Share		 $0.47 $0.43 $0.36 $0.39 $0.34 $0.34 $0.43 $0.48 $0.52 $0.58 $0.62
Tangible Book Value per Share		 ($0.47) ($0.41) ($0.48) ($0.43) ($0.48) ($0.46) ($0.37) ($0.31) ($0.25) ($0.19) ($0.13)
Total Capital		 14 14 12 13 15 17 21 23 25 26 28
Total Debt		 0.00 0.00 0.00 0.00 3.96 6.02 7.36 7.30 7.30 7.31 7.32
Total Long-Term Debt		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Net Debt		 -2.70 -4.22 -6.10 -6.92 -3.74 -3.83 -4.86 -4.66 -4.97 -4.74 -5.31
Capital Expenditures (CapEx)		 0.02 0.00 0.01 0.00 0.01 0.01 0.01 0.02 0.01 0.00 0.01
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 -7.79 -8.92 -9.28 -8.78 -8.51 -9.90 -10 -9.88 -9.90 -9.17 -9.55
Debt-free Net Working Capital (DFNWC)		 -5.09 -4.70 -3.18 -1.86 -0.81 -0.05 1.85 2.07 2.36 2.88 3.08
Net Working Capital (NWC)		 -5.09 -4.70 -3.18 -1.86 -4.77 -6.07 -5.51 -5.22 -4.94 -4.43 -4.25
Net Nonoperating Expense (NNE)		 -0.24 -0.02 3.28 -0.06 2.05 0.31 -1.16 0.19 0.18 0.16 0.09
Net Nonoperating Obligations (NNO)		 -2.70 -4.22 -6.10 -6.92 -3.74 -3.83 -4.86 -4.66 -4.97 -4.74 -5.31
Total Depreciation and Amortization (D&A)		 0.16 0.31 0.31 0.31 0.31 0.31 0.32 0.32 0.32 0.31 0.31
Debt-free, Cash-free Net Working Capital to Revenue		 -19.15% -21.01% -20.79% -18.85% -17.65% -20.31% -21.15% -20.04% -20.13% -18.83% -19.78%
Debt-free Net Working Capital to Revenue		 -12.51% -11.07% -7.12% -3.99% -1.68% -0.10% 3.78% 4.20% 4.80% 5.93% 6.37%
Net Working Capital to Revenue		 -12.51% -11.07% -7.12% -3.99% -9.90% -12.45% -11.23% -10.59% -10.03% -9.10% -8.79%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.00 ($0.09) $0.02 ($0.07) $0.01 $0.08 $0.02 $0.02 $0.03 $0.02
Adjusted Weighted Average Basic Shares Outstanding		 28.09M 30.02M 28.86M 30.35M 30.42M 31.03M 30.68M 31.23M 31.63M 32.00M 31.79M
Adjusted Diluted Earnings per Share		 $0.00 $0.00 ($0.09) $0.02 ($0.07) $0.01 $0.08 $0.02 $0.02 $0.03 $0.02
Adjusted Weighted Average Diluted Shares Outstanding		 28.09M 33.51M 28.86M 33.23M 30.42M 32.14M 31.50M 32.07M 32.33M 32.44M 32.27M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 32.62M 32.28M 32.55M 32.51M 32.65M 32.46M 32.83M 32.87M 32.91M 33.45M 33.76M
Normalized Net Operating Profit after Tax (NOPAT)		 -0.29 0.06 0.46 0.60 0.06 0.52 1.20 0.94 0.73 1.02 0.75
Normalized NOPAT Margin		 -2.85% 0.46% 3.82% 5.02% 0.55% 4.14% 9.65% 7.60% 6.17% 8.40% 6.22%
Pre Tax Income Margin		 -0.42% 0.98% -23.00% 5.94% -16.49% 1.82% 19.04% 6.26% 4.71% 7.28% 6.18%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 4.58 0.00
NOPAT to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 4.13 0.00
EBIT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 4.56 0.00
NOPAT Less CapEx to Interest Expense		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 4.12 0.00
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Augmented Payout Ratio		 -28.96% -93.57% -14.64% -24.61% -17.03% -24.02% 73.85% 69.98% 19.85% 1.63% 1.88%

Financials Breakdown Chart

Key Financial Trends

Research Solutions (NASDAQ:RSSS) has shown a meaningful recovery in profitability and cash generation over the past several years. Revenue increased from approximately $10.1 million in Q1 2024 to $12.1 million in Q4 2026, while quarterly results moved from operating and net losses in early fiscal 2024 to sustained profitability throughout fiscal 2026. However, revenue has remained relatively flat near $12 million in recent quarters, suggesting that growth has moderated.

Profitability has improved substantially from the losses recorded in Q1 and Q2 2024. Operating income reached $1.2 million in Q4 2025 and remained positive at $842,000 in Q4 2026. Net income was $666,000 in the latest quarter, although that was down from $860,000 in Q3 2026 and $2.4 million in Q4 2025. The prior-year quarter benefited from unusually high other income, making the year-over-year comparison less representative of core operating performance.

Cash generation remains a key strength. Research Solutions produced positive operating cash flow in every quarter provided, including $1.8 million in Q4 2026. Cash and equivalents increased from $4.2 million in Q3 2024 to $12.1 million in Q3 2026. Still, substantial recurring financing cash outflows and a balance sheet with current liabilities exceeding current assets warrant investor attention.

  • Consistent operating cash flow: Operating cash flow remained positive across all reported quarters and reached $1.8 million in Q4 2026, more than double quarterly net income.
  • Improved profitability: The company has progressed from operating losses in Q1 and Q2 2024 to positive operating income in every subsequent quarter provided.
  • Higher revenue base: Quarterly revenue has generally stabilized around $12 million, compared with approximately $10.1 million in Q1 2024.
  • Expanding equity balance: Total equity rose from $6.9 million in Q1 2024 to $19.1 million in Q3 2026, supported by improved retained earnings and ongoing profitability.
  • Limited capital expenditure needs: Property and equipment purchases were modest, totaling only $11,000 in Q4 2026, which allows more operating cash to remain available for other uses.
  • Gross margins have improved over the longer term: Gross margin was approximately 33% in Q1 2024 and reached about 53% in Q4 2026, but the latest quarter declined from roughly 52% in Q3 2026 and remains sensitive to cost-of-revenue changes.
  • Deferred revenue is substantial: Current deferred revenue of $11.1 million may support future recognized revenue, but it also represents services or obligations that the company must fulfill before recognizing the associated sales.
  • Recent earnings momentum weakened: Q4 2026 revenue declined slightly quarter over quarter, while operating income fell about 19% and net income dropped about 23% from Q3 2026.
  • Financing activities consume cash: Financing cash outflows were $1.2 million in Q4 2026 and exceeded $1 million in each fiscal 2026 quarter provided, limiting the amount of operating cash retained.
  • Liquidity and leverage require monitoring: At Q3 2026, current liabilities of $25.1 million exceeded current assets of $20.7 million, while short-term debt stood at $7.3 million. Goodwill and intangible assets also totaled approximately $25.2 million, creating exposure to potential impairment charges.
09/20/26 05:27 AM ETAI Generated. May Contain Errors.

Research Solutions Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Research Solutions' financial year ends in June. Their financial year 2026 ended on June 30, 2026.

Research Solutions' net income appears to be on a downward trend, with a most recent value of $2.82 million in 2026, falling from -$497.86 thousand in 2016. The previous period was $1.27 million in 2025. View Research Solutions' forecast to see where analysts expect Research Solutions to go next.

Research Solutions' total operating income in 2026 was $3.59 million, based on the following breakdown:
  • Total Gross Profit: $25.07 million
  • Total Operating Expenses: $21.48 million

Over the last 10 years, Research Solutions' total revenue changed from $24.09 million in 2016 to $48.31 million in 2026, a change of 100.5%.

Research Solutions' total liabilities were at $24.96 million at the end of 2026, a 22.5% decrease from 2025, and a 294.2% increase since 2016.

In the past 10 years, Research Solutions' cash and equivalents has ranged from $4.91 million in 2018 to $13.55 million in 2023, and is currently $12.63 million as of their latest financial filing in 2026.

Over the last 10 years, Research Solutions' book value per share changed from 0.33 in 2016 to 0.62 in 2026, a change of 90.4%.


Related Companies

Financial statements for NASDAQ:RSSS last updated on 9/11/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
$40,000,000,000,000
The national debt just hit 40 trillion dollars, and the U.S. now spends more on interest payments than on its ...
American Alternative | Sponsoredtc pixel
“Elon’s nightmare” could fund your retirement
Marc Chaikin, the 60 year Wall Street veteran whose Chaikin Money Flow indicator sits on every Bloomberg termi...
Chaikin Analytics | Sponsoredtc pixel
You’ve never seen anything like this before
For centuries, families like the Rothschilds, Morgans, and Rockefellers have quietly used one overlooked type ...
Porter & Company | Sponsoredtc pixel
Bank of America: 'Digital Dollar Inevitable'
Bank of America just revealed your expiration date. In their Bloomberg interview, they didn't just predict the...
Decentralized Masters | Sponsoredtc pixel
My top 3 AI picks for the next decade
Alexander Green bought Apple in 1996, recommended Nvidia at a split-adjusted 66 cents in 2004, and picked up A...
The Oxford Club | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
NVDA CEO says it’s a "once-in-a-generation opportunity"
NVIDIA CEO Jensen Huang calls a little-known AI niche a once-in-a-generation opportunity, and it has nothing t...
Monument Traders Alliance | Sponsoredtc pixel
Trump goes "all-in" on Grand Canyon energy breakthrough
A drilling crew near the Grand Canyon uncovered a clean energy well producing nearly eight times the output of...
Behind the Markets | Sponsoredtc pixel